![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 02, 2017 1:22:11 PM
EAPH / Herbs of Kedem - $2,000,000 in Revenue
EAPH / AMFE (Stock Trading at .09) Investment Ownership - RUp-listing in June
EAPH / iBLISS ACQUISITION – Acquisition Complete - $15,000,000 in Revenue
EAPH / GEDEON RICHTER BIG PHARMA JV – Gynofit - Est, $2.5 - $5,000,000 in Revenue
EAPH / BAYER BIG PHARMA JV – Al-Sense Est. $3,5 -$7,000,000 - Pending
EAPH / Assorted Misc Generic Cancer Drugs (36 total) in various states of approval
EAPH / JAMACIA MMJ JV – MMJ producer JV pending with MMJ
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM